Skip to main content

MoneyWorks4Me

Granules India informs about press release

17 Dec 2024 Evaluate
Granules India has informed that it enclosed press release ‘Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the US’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..